Cure51 raised €15M in a Seed round in Mar 2024. The company is based in Paris, France. Investors in the round: Hitachi Ventures, Life Extension Ventures, Olivier Pomel and 2 others. Data as of 7 Aug 2026.
Reported in EUR — no conversion. €15M
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
